Preview

Russian Journal of Gastroenterology, Hepatology, Coloproctology

Advanced search

Clinical and genetic aspects of inflammatory bowel diseases

Abstract

Aim of investigation. To study clinical and epidemiologic features of inflammatory bowel diseases (IBD) and their relation to TNF-a, and СD14 genes polymorphism in Novosibirsk population.

Materials and methods. According to medical aid appealability and archival documents, data for 527 IBD patients were obtained: 375 had ulcerative colitis (UC), 277 – Crohn’s disease (CD) and 28 – «indeterminate» colitis. Clinical analysis was carried out by type and course of disease, localization and prevalence of process. In 120 patients (57 – with CD, 63 – with UC) frequency of TNF-a (–G308A) and СD14 (–С260Т) genes polymorphism was studied in comparison to population data.

Results. Clinical and epidemiologic characteristics of patients with IBD in Novosibirsk essentially do not differ from the scores obtained in other regions of Russia. Frequency of TNF-a gene –G308A polymorphism in city inhabitants with IBD, significantly differed from population data: genotype А/А at IBD was detected 4,7 times, and at CD – 7,7 times is more frequently, than in general population, A allele carriage was 1,7 and 2,2 times more frequent respectively. Frequency of CD14 gene –С260Т polymorphism at IBD also significantly differed from population: С/С genotype at IBD is revealed 1,8, and at UC – 2,2 times more frequently, than in general population, frequency of Т/Т genotype is 2,5 times higher at CD, than in general population.

Conclusion. Contribution of the revealed gene polymorphism to IBD predisposition at Novosibirsk inhabitants is quite high. Further studies are necessary.

About the Authors

Ye. Yu. Valuyskikh

Russian Federation


I. O. Svetlova

Russian Federation


S. A. Kurilovich

Russian Federation


M. F. Osipenko

Russian Federation


V. N. Maximov

Russian Federation


M. I. Voyevoda

Russian Federation


References

1. Адлер Г. Болезнь Крона и язвенный колит: Пер. с нем. – М.: ГЭОТАР-МЕДИЦИНА, 2001. – 500 с.

2. Белоусова Е.А. Иммунные механизмы при воспалительных заболеваниях кишечника и принципы селективной иммунокоррекции (По материалам 15-й сессии «Современные проблемы физиологии и патологии пищеварения», Пущино-на-Оке 5–8 апреля 1999 г.) // Рос. журн. гастроэнтерол. гепатол. колопроктол. – 1999. – Т. 9, № 4. – С. 48–57.

3. Белоусова Е.А. Язвенный колит и болезнь Крона. – Тверь: ООО «Издательство «Триада», 2002. – 128 с.

4. Симбирцев А.С., Громова А.Ю. Функциональный полиморфизм генов регуляторных молекул воспаления // Цитокины и воспаление. – 2005. – № 1. – С.12–17.

5. Хаитов P.M., Алексеев Л.П. Генетика иммунного ответа // Иммунология. – 1998. – № 5. – С. 11–15.

6. Ahmad T., Satsangi J. et al. The genetics of inflammatory bowel disease // Aliment. Pharmacol. Ther. – 2001. – Vol. 15, N 6. – P. 731–748.

7. Cantor M.J., Nickerson P., Bernstein C.N. The role of cytokine gene polymorphisms in determining disease susceptibility and phenotype in inflammatory bowel disease // Am. J. Gastroenterol. – 2005. – Vol. 100, N 5. – Р. 1134–1142.

8. Dalton H.R., Jewell D.P. The immunology of inflammatory bowel disease // Inflammatory bowel disease / G. Jamerot, ed. – 1992. – Р. l25–147.

9. Dombal. Epidemiology of inflammatory bowel disease. – Oxford medical publications, 1993. – Р. 96–127.

10. Ekbom A. The IBD epidemiology // A report from the 1st International meeting on chronic inflammatory bowel disease. – Madrid, 2000. – May 4–5.

11. Gibson P.R. Future directions in Crohn’s disease: changing the paradigm by enhancing mucosal barrier function // World Gastroenterol. News. – 2005. – N 10. – P. 51–53.

12. Henderson B., Poole S., Wilson M. Bacterial modulins: a novel class of virulence factors which cause host tissue pathology by inducing cytokine synthesis // Microbiol. Rev. – 1996. – Vol. 60, N 2. – Р. 316–341.

13. Hinshaw L.B. Cellular and molecular aspects of endotoxin reactions // Elsevier Sci. Publ. – 1990. – Р. 509–519.

14. Holmes C.L., Russell J.A., Walley K.R. Genetic polymorphisms in sepsis and septic shock: role in prognosis and potential for therapy // Chest. – 2003. – Vol. 124. – Р. 1103–1115.

15. Klein W., Tromm A., Griga T. et al. Interaction of polymorphisms in the CARD15 and CD14 genes in patients with Crohn disease // Scand. J. Gastroenterol. – 2003. – Vol. 38, N 8. – Р. 834–836.

16. Mathison J.C., Ulevitch R.J. The clearance, tissue distribution and cellular localization of intravenously injected lipopolysaccharide in rabbits // J. Immunol. – 1979. – Vol. 123. – Р. 2133–2143.

17. Mittal R.D., Manchanda P.K., Bid H.K., Gho-shal U.C. Analysis of polymorphisms of tumor necrosis factor-alpha and polymorphic xenobiotic metabolizing enzymes in inflammatory bowel disease: study from northern India // J. Gastroenterol. Hepatol. – 2007. – Vol. 22, N 6. – Р. 920–924.

18. Sanborn W. Steroid-dependent Crohn’s disease // Scand. J. Gastroenterol. – 2000. – Vol. 38, N 14 (suppl. 100).

19. Schoeffel U., Pelz K., Haring, R.U. et al. Inflammatory consequences of the translocation of bacteria and endotoxin to mesenteric lymph nodes // Am. J. Surg. – 2000. – Vol. 180, N 1. – Р. 65–72.

20. Shivananda S., Lennard-Jones J., Logan R. et al. Incidence of inflammatory bowel diseases across Europe: is there a difference between north and south? Results of the collaborative study on inflammatory bowel diseases (EC-IBD) // Gut. – 1996. – Vol. 39, N 5. – P. 690–697.

21. Ulmer A.J., Flad H., Rietschel T. et al. Induction of proliferation and cytokine production in human T-lymphocytes by lipopolysaccharide (LPS) // Toxicology. – 2000. – Vol. 152, N 1–3. – Р. 37–45.

22. Van Deventer S.J. Tumor necrosis factor and Crohn’s disease // Gut. – 1997. – Vol. 40, N 4. – Р. 443–448.

23. Wang F., Tahara T., Arisawa T. et al. Genetic polymorphisms of CD14 and Toll-like receptor-2 (TLR2) in patients with ulcerative colitis // J. Gastroenterol. Hepatol. – 2007. – Vol. 22, N 6. – Р. 925–929.

24. Zeitz M. Role of immunological mechanisms in inflammatory bowel disease // Innovative concepts in inflammatory bowel diseases. Falk Symposium N 105, 1998. – Р. 33.


Review

For citations:


Valuyskikh Ye.Yu., Svetlova I.O., Kurilovich S.A., Osipenko M.F., Maximov V.N., Voyevoda M.I. Clinical and genetic aspects of inflammatory bowel diseases. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2008;18(6):68-74. (In Russ.)

Views: 72

JATS XML

ISSN 1382-4376 (Print)
ISSN 2658-6673 (Online)